Immunosuppression and Neoplasia

[1]  G. Papadopulu,et al.  Zur Wirkung von Diäthylnitrosamin (DAENA) und Influenza-Viren auf die Entstehung von Lungencarcinomen bei Mäusen , 2004, Zeitschrift für Krebsforschung und Klinische Onkologie.

[2]  T. Starzl,et al.  Malignant tumors arising de novo in immunosuppressed organ transplant recipients. , 1972 .

[3]  H. Schreiber,et al.  Induction of lung cancer in germfree, specific-pathogen-free, and infected rats by N-nitrosoheptamethyleneimine: enhancement by respiratory infection. , 1972, Journal of the National Cancer Institute.

[4]  R. Schwartz,et al.  Immunologic induction of malignant lymphoma: genetic factors in the graft-versus-host model. , 1972, Journal of the National Cancer Institute.

[5]  G. L. Bartlett.  Effect of host immunity on the antigenic strength of primary tumors. , 1972, Journal of the National Cancer Institute.

[6]  E. Farber,et al.  The effects of cytosine arabinoside upon proliferating epithelial cells. , 1972, Cancer research.

[7]  B. Siegel,et al.  Immunologic stimuli in relation to leukemogenesis. 1. Potentiation of Rauscher viral leukemia by Freund's adjuvants. , 1972, Journal of the National Cancer Institute.

[8]  D. Malamud,et al.  Inhibition of cell proliferation by azathioprine. , 1972, Cancer research.

[9]  J. Bach,et al.  Activities of immunosuppressive agents in vitro. II. Different timing of azathioprine and methotrexate in inhibition and stimulation of mixed lymphocyte reaction. , 1972, Clinical and experimental immunology.

[10]  R. Prehn.  The Immune Reaction as a Stimulator of Tumor Growth , 1972, Science.

[11]  F. Black,et al.  Tumour induction by cell-free extracts derived from mice with graft versus host disease. , 1972, Nature: New biology.

[12]  J. Kieler,et al.  Tumorigenicity and isoimmunizing properties of C3H mouse cells undergoing "spontaneous" malignant conversion in vitro. , 1972, Journal of the National Cancer Institute.

[13]  N. Talal,et al.  The spectrum of benign to malignant lymphoproliferation in Sjögren's syndrome. , 1972, Clinical and experimental immunology.

[14]  S. Datta,et al.  Cell-mediated immunity in polyoma oncogenesis. , 1972, European journal of cancer.

[15]  H. Gleichmann,et al.  Differential immunogenicity of D- and K-end antigens and its possible significance for HL-A. , 1972, Transplantation.

[16]  M. Topilsky,et al.  Lymphocyte response in sarcoidosis. , 1972, Lancet.

[17]  M. L. Duran-Reynals.  Combined neoplastic effects of vaccinia virus and 3-methylcholanthrene. I. Studies with mice of different inbred strains. , 1972, Journal of the National Cancer Institute.

[18]  M. R. Robertson,et al.  Skin cancer and immunosuppression. , 1971, Lancet.

[19]  Warwick Gp.  Effect of the cell cycle on carcinogenesis. , 1971 .

[20]  T. Merigan,et al.  Viral infections in man associated with acquired immunological deficiency states. , 1971, Federation proceedings.

[21]  L. Xerri,et al.  Depression of homograft rejection and graft-versus-host reactivity following 7,12-dimethylbenz(a)anthracene exposure in the rat. , 1971, Cancer research.

[22]  W. Baird,et al.  Effects of phorbol and four diesters of phorbol on the incorporation of tritiated precursors into DNA, RNA, and protein in mouse epidermis. , 1971, Cancer research.

[23]  G. Parmiani.  Skin-graft rejection during lymphomagenesis in urethan-treated mice. , 1971, Journal of the National Cancer Institute.

[24]  S. Kountz,et al.  Analysis of the immunosuppressive and oncogenic effects of heterologous antilymphocyte serum. , 1971, American journal of surgery.

[25]  L. Borella.  The immunosuppressive effects of Rauscher leukemia virus upon spleen cells cultured in cell-impermeable diffusion chambers. II. Effects upon IgM and IgG immunologic memory and on response to phytohemagglutinin and stimulation with allogeneic cells. , 1971, Journal of immunology.

[26]  N. Haran‐Ghera,et al.  Immunosuppression by the radiation leukemia virus and its relation to lymphatic leukemia development , 1971, International journal of cancer.

[27]  M. Lappé.  Failure of long-term immunologic control of 3-methylcholanthrene-induced skin tumors in the autochthonous host. , 1971, Journal of the Reticuloendothelial Society.

[28]  S. Nehlsen.  Prolonged administration of antithymocyte serum in mice. I. Observations on cellular and humoral immunity. , 1971, Clinical and experimental immunology.

[29]  E. Simpson,et al.  Prolonged administration of antithymocyte serum in mice. II. Histopathological investigation. , 1971, Clinical and experimental immunology.

[30]  M. Bendinelli.  Effect of Friend Leukemia Virus and Rowson-Parr Virus on Immunological Maturation of Mice , 1971, Infection and immunity.

[31]  R. Blanden.  MECHANISMS OF RECOVERY FROM A GENERALIZED VIRAL INFECTION: MOUSEPOX , 1971, The Journal of experimental medicine.

[32]  B. Greenwood,et al.  Immunosuppression in murine malaria. I. General characteristics. , 1971, Clinical and experimental immunology.

[33]  G. Shklar,et al.  Azathioprine effects on the development of hamster pouch carcinomas. , 1971, Archives of pathology.

[34]  J. Najarian,et al.  Primary carcinoma of the cervix appearing in immunosuppressed renal transplant recipient. , 1971, American journal of obstetrics and gynecology.

[35]  C. Berard,et al.  MALIGNANT LYMPHOMAS AND PLASMACYTOSIS IN MICE UNDER PROLONGED IMMUNOSUPPRESSION AND PERSISTENT ANTIGENIC STIMULATION , 1971, Transplantation.

[36]  R. Prehn.  Immunosurveillance, Regeneration and Oncogenesis1 , 1971 .

[37]  K. Hellström,et al.  Cell-Mediated Immunity to Human Tumor Antigens , 1971 .

[38]  H. Friedman,et al.  Immunosuppression by Tumor Viruses: Effects of Leukemia Virus Infection on the Immune Response**Some of the studies described here were supported by research grants from the U. S. National Science Foundation, the American Cancer Society, and the Damon Runyon Cancer Fund. , 1971 .

[39]  B. A. Rubin.  Alteration of the homograft response as a determinant of carcinogenicity. , 1971, Progress in experimental tumor research.

[40]  N. Haran‐Ghera,et al.  Effect of heterologous antithymocyte serum on mouse skin tumorigenesis. , 1971, Journal of the National Cancer Institute.

[41]  G. Haughton,et al.  Immunosuppression by antilymphocyte serum and its effect on tumors indduced by 3-methylcholanthrene in mice. , 1971, Journal of the National Cancer Institute.

[42]  R. Schwartz,et al.  Malignancy as a complication of immunosuppressive therapy. , 1971, Advances in internal medicine.

[43]  L. R. Barker.  Experimental malaria: effects upon the immune response to different antigens. , 1971, The Journal of infectious diseases.

[44]  K. Pritzker,et al.  Malignant tumours following immunosuppressive therapy. , 1970, Canadian Medical Association journal.

[45]  M. Hirsch,et al.  Leukemia virus activation in chronic allogeneic disease. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[46]  N. Wedderburn.  Effect of concurrent malarial infection on development of virus-induced lymphoma in Balb-c mice. , 1970, Lancet.

[47]  I. Green,et al.  Croton Oil Induced Suppression of the Immune Response of Guinea-pigs , 1970, Nature.

[48]  W. Frable,et al.  Cervical dysplasia and cancer developing in women on immunosuppression therapy for renal homotransplantation , 1970 .

[49]  J. Playfair,et al.  Deficient cell-mediated immunity in adult NZB mice. , 1970, Transplantation.

[50]  R. Blanden.  MECHANISMS OF RECOVERY FROM A GENERALIZED VIRAL INFECTION: MOUSEPOX , 1970, The Journal of experimental medicine.

[51]  D. Keast.  Immunosurveillance and cancer. , 1970, Lancet.

[52]  R. Schwartz,et al.  Chronic allogeneic disease. II. Development of lymphomas. , 1970 .

[53]  J. Mannick,et al.  The effects of immunosuppression on the induction and immunogenicity of chemically induced sarcomas. , 1970, Surgery.

[54]  P. Nowell,et al.  Parental-F1 Hybrid Bone Marrow Chimeras: High Incidence of Donor-Type Lymphomas 1 , 1970, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[55]  B. Fisher,et al.  Further observations concerning effects of antilymphocyte serum on tumor growth: with special reference to allogeneic inhibition. , 1970, Cancer research.

[56]  V. Defendi,et al.  Inhibition of phytohemagglutinin- and alloantigen-induced lymphocyte stimulation by Rauscher leukemia virus. , 1970, Journal of the National Cancer Institute.

[57]  H. Balner.  Immunosuppression and neoplasia. , 1970, Revue europeenne d'etudes cliniques et biologiques. European journal of clinical and biological research.

[58]  J. Durant,et al.  Prolonged immunological disorder terminating in hematological malignancy: A human analogue of animal disease? , 1970, Annals of internal medicine.

[59]  R. Prehn,et al.  The predictive value of skin allograft survival times during the development of urethan-induced lung adenomas in BALB-c mice. , 1970, Cancer research.

[60]  G. O'Conor,et al.  Persistent immunologic stimulation as a factor in oncogenesis, with special reference to Burkitt's tumor , 1970 .

[61]  H. Jeejeebhoy,et al.  Heterologous antilymphocyte serum (ALS) hastens the appearance of methylcholanthrene-induced tumours in mice. , 1970, Transplantation.

[62]  M. K. Jensen.  Effect of azathioprine on the chromosome complement of human bone marrow cells , 1970, International journal of cancer.

[63]  Salaman Mh.  Immunodepression by mammalian viruses and plasmodia. , 1970 .

[64]  J. East.  Immunopathology and neoplasms in New Zealand black (NZB) and SJL-J mice. , 1970, Progress in experimental tumor research.

[65]  F. Burnet.  The concept of immunological surveillance. , 1970, Progress in experimental tumor research.

[66]  J. Ball.  Immunosuppression and carcinogenesis: contrasting effects with 7,12-dimethylbenz[a]anthracene, benz[a]pyrene, and 3-methylcholanthrene. , 1970, Journal of the National Cancer Institute.

[67]  R. Howard,et al.  Effect of virus infections on the function of the immune system. , 1970, Annual review of microbiology.

[68]  H. Friedman,et al.  Murine Virus Leukaemogenesis: Relationship between Susceptibility and Immunodepression , 1969, Nature.

[69]  R. Treat,et al.  THE EFFECT OF ANTILYMPHOCYTE SERUM ON THE INDUCTION AND GROWTH OF TUMOR IN THE ADULT MOUSE1 , 1969 .

[70]  O. Stutman.  Carcinogen-Induced Immune Depression: Absence in Mice Resistant to Chemical Oncogenesis , 1969, Science.

[71]  H. Balner,et al.  Increased Oncogenic Effect of Methylcholanthrene after Treatment with Anti-lymphocyte Serum , 1969, Nature.

[72]  D. A. Woods.  Influence of Antilymphocyte Serum on DMBA Induction of Oral Carcinomas , 1969, Nature.

[73]  E. Klein.  TUMOR‐SPECIFIC TRANSPLANTATION ANTIGENS* , 1969 .

[74]  D. Vredevoe,et al.  Effect of antilymphocytic and antithymocytic sera on the development of mouse lymphoma. , 1969, Cancer research.

[75]  R. Good,et al.  Essential relationship between the lymphoid system, immunity, and malignancy. , 1969, National Cancer Institute monograph.

[76]  M. Branca,et al.  Autoimmune reactions and malignant changes in germ-free New Zealand Black mice. , 1969, Clinical and experimental immunology.

[77]  D. Vidt,et al.  Development of reticulum-cell sarcoma at the site of antilymphocyte globulin injection in a patient with renal transplant. , 1969, The New England journal of medicine.

[78]  M. Hirsch,et al.  Unexpected High Incidence of Tumours in Thymectomized Mice treated with Anti-lymphocytic Globulin and Mycobacterium leprae , 1969, Nature.

[79]  K. Nomoto,et al.  Immunologic properties of methylcholanthrene-induced sarcomas of neonatally thymectomized mice. , 1969, Journal of the National Cancer Institute.

[80]  M. Vandeputte.  Antilymphocytic serum and polyoma oncogenesis in rats. , 1969, Transplantation proceedings.

[81]  G. Parmiani,et al.  Jmmunodepressive and Leukemogenic Effects of Urethan in C3Hf and SWR Mice∗ , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[82]  S. F. Petropulos,et al.  Enhancement of responses to chemical carcinogens by nononcogenic viruses and antimetabolites. , 1969, Progress in experimental tumor research.

[83]  J. Stjernswärd.  Immunosuppression by carcinogens. , 1969, Antibiotica et chemotherapia. Fortschritte. Advances. Progres.

[84]  L. Law.  Studies of the significance of tumor antigens in induction and repression of neoplastic diseases: presidential address. , 1969, Cancer research.

[85]  B. Terracini,et al.  Chemical carcinogenesis in infant animals. , 1969, Progress in experimental tumor research.

[86]  A. Allison,et al.  Effects of Antilymphocyte Serum on Induction of Tumours and Leukaemia by Murine Sarcoma Virus , 1968, Nature.

[87]  M. Hirsch,et al.  Effects of anti-lymphoid sera on viral infections. , 1968, Lancet.

[88]  J. Trentin,et al.  Enhancement by Thymectomy of Tumor Formation by Oncogenic Adenoviruses∗ , 1968, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[89]  K. Hellmann,et al.  Antilymphocytic serum and tumour dissemination. , 1968, British medical journal.

[90]  S. Millian,et al.  Antibody production by mice infected with selected murine oncogenic agents , 1968, Cancer.

[91]  T. Casey.  Azathioprine (Imuran) administration and the development of malignant lymphomas in NZB mice. , 1968, Clinical and experimental immunology.

[92]  M. Hirsch,et al.  Effects of Anti-thymocyte Serum on Rauscher Virus Infection of Mice , 1968, Nature.

[93]  S. Johnson.  The effect of thymectomy and of the dose of 3-methylcholanthrene on the induction and antigenic properties of sarcomas in C56Bl mice. , 1968, British Journal of Cancer.

[94]  M. Volkert,et al.  THE PROVOCATION OF LATENT LYMPHOCYTIC CHORIOMENINGITIS VIRUS INFECTIONS IN MICE BY TREATMENT WITH ANTILYMPHOCYTIC SERUM , 1968, The Journal of experimental medicine.

[95]  F. Dietrich,et al.  Haemagglutinin production in tumour‐bearing and leukaemic mice , 1968, International journal of cancer.

[96]  A. Allison,et al.  Effects of Antilymphocyte Serum on Virus Oncogenesis , 1968, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[97]  A. Meshorer,et al.  Studies on leukemia development in the SJL/J strain of mice. , 1967, Journal of the National Cancer Institute.

[98]  N. Trainin,et al.  Enhancement of lung adenoma formation by neonatal thymectomy in mice treated with 7,12‐dimethylbenz(a)anthracene or urethan , 1967, International journal of cancer.

[99]  A. Allison,et al.  Increased Tumour Induction by Adenovirus Type 12 in Thymectomized Mice and Mice treated with Anti-lymphocyte Serum , 1967, Nature.

[100]  Jones Jv.  Development of sensitivity oto dinitrochlorobenzene in patients with sarcoidosis. , 1967 .

[101]  J. Berg.  The incidence of multiple primary cancers. I. Development of further cancers in patients with lymphomas, leukemias, and myeloma. , 1967, Journal of the National Cancer Institute.

[102]  J. Stjernswärd.  Further immunological studies of chemical carcinogenesis. , 1967, Journal of the National Cancer Institute.

[103]  A. Allison,et al.  Observations on thymectomy and carcinogenesis. , 1967, Cancer research.

[104]  R. G. Doell,et al.  Immune reactivity prior to development of thymic lymphoma in C57BL mice , 1967, International journal of cancer.

[105]  D. Miller.  The association of immune disease and malignant lymphoma. , 1967, Annals of internal medicine.

[106]  A. Ley,et al.  Coombs'-positive hemolytic anemia in Hodgkin's disease. , 1967, Annals of internal medicine.

[107]  G. Hitchings,et al.  SOME ASPECTS OF IMMUNOSUPPRESSION , 1966 .

[108]  B. Siegel,et al.  Serum Agglutinin Levels to Sheep Red Blood Cells in Mice Infected With Rauscher Virus.∗ , 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[109]  G. Shklar,et al.  The effect of methotrexate on chemical carcinogenesis of hamster buccal pouch. , 1966, Cancer research.

[110]  R. Good,et al.  Chediak-Higashi syndrome. Observations on the nature of the associated malignancy. , 1966, Laboratory investigation; a journal of technical methods and pathology.

[111]  R. Schwartz,et al.  ENHANCEMENT OF ANTIBODY SYNTHESIS BY 6-MERCAPTOPURINE , 1966, The Journal of experimental medicine.

[112]  M. Pike,et al.  Effect of Neonatal Thymectomy on the Induction of Papillomata and Carcinomata by 3,4-Benzopyrene in Mice , 1966, Nature.

[113]  E. Stadlan,et al.  The development of malignancy in the course of the Aldrich syndrome. , 1966, The Journal of pediatrics.

[114]  L. Law.  Studies of thymic function with emphasis on the role of the thymus in oncogenesis. , 1966, Cancer research.

[115]  H. Balner,et al.  Neonatal thymectomy and tumor induction with methylcholanthrene in mice. , 1966, Journal of the National Cancer Institute.

[116]  N. Cremer,et al.  Antibody formation, latency and leukemia: infection with Moloney virus. , 1966, Journal of immunology.

[117]  E. Boder,et al.  Immunologic Studies in Ataxia-Telangiectasia , 1966 .

[118]  R. Schwartz,et al.  Autoimmune hemolytic anemia: clinical correlations and biological implications. , 1966, Seminars in hematology.

[119]  R. Ting,et al.  Immunologic Competence and Induction of Neoplasms by Polyoma Virus , 1965, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[120]  J. Miller,et al.  Effect of Neonatal Thymectomy on the Induction of Sarcomata in C57BL Mice , 1965, Nature.

[121]  F. Gunz,et al.  Leukemia and cancer in the same patient , 1965, Cancer.

[122]  V. Defendi,et al.  The role of the thymus in carcinogenesis. , 1964, The Wistar Institute symposium monograph.

[123]  Berenbaum Mc.  EFFECTS OF CARCINOGENS ON IMMUNE PROCESSES. , 1964 .

[124]  J. East,et al.  THE APPEARANCE OF A HEPATOTROPHIC VIRUS IN MICE THYMECTOMIZED AT BIRTH , 1963, The Journal of experimental medicine.

[125]  R. Prehn.  FUNCTION OF DEPRESSED IMMUNOLOGIC REACTIVITY DURING CARCINOGENESIS. , 1963, Journal of the National Cancer Institute.

[126]  J. Miller,et al.  Effect of Thymectomy on the Induction of Skin Tumours by 3,4-Benzopyrene , 1963, Nature.

[127]  D. Metcalf.  INDUCTION OF RETICULAR TUMOURS IN MICE BY REPEATED ANTIGENIC STIMULATION. , 1963, Acta - Unio Internationalis Contra Cancrum.

[128]  L. Old,et al.  ANTIGENIC PROPERTIES OF CHEMICALLY INDUCED TUMORS * , 1962 .

[129]  O. Linder.  Survival of skin homografts in methylcholanthrene-treated mice and in mice with spontaneous mammary cancers. , 1962, Cancer Research.

[130]  D. Metcalf.  Reticular Tumours in Mice Subjected to Prolonged Antigenic Stimulation , 1961, British Journal of Cancer.

[131]  H. A. Gordon.  MORPHOLOGICAL AND PHYSIOLOGICAL CHARACTERIZATION OF GERMFREE LIFE * , 1959 .

[132]  J. Weston,et al.  Epithelial atypias with chemotherapy in 100 acute childhood leukemias , 1955, Cancer.

[133]  T. McKinley,et al.  Reduced Antibody Titers in Mice Treated with Carcinogenic and Cancer Chemotherapeutic Agents , 1952, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.